Skip to main content
Clinical Trials/CTRI/2021/09/036417
CTRI/2021/09/036417
Completed
N/A

A prospective study to evaluate the clinical outcomes and dose volume histogram (DVH) parameters of adaptive intensity modulated radiotherapy in the treatment of patients with head and neck cancers

svims tirupati0 sites64 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
svims tirupati
Enrollment
64
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
December 21, 2022
Last Updated
3 years ago
Study Type
Observational

Investigators

Sponsor
svims tirupati

Eligibility Criteria

Inclusion Criteria

  • 1\. histopathologically proven squamous cell carcinoma of head and neck
  • 2\.cancers of oralcavity, oropharynx, hypopharynx and larynx
  • 3\. stage 3 to stage 4b disease
  • 4\. patients with ECOG performance status 0 to 2
  • 5\. patients who has given approved informed consent

Exclusion Criteria

  • 1\. patients previously treated with surgery, chemotherapy or radiotherapy
  • 2\. patients with distant metastasis
  • 3\.patients with ECOG performance status 3 and 4
  • 4\.pregnant women and lactating mothers

Outcomes

Primary Outcomes

Not specified

Similar Trials